Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year
Like many industries preparing for Donald Trump's second term as president, the prospects for the healthcare industry are a mixed bag. But headwinds, like tariffs and drug pricing, are clearly blowing strong. And analysts on the sidelines are waiting and watching.
Trump has pledged tariffs of 10% on global imports, 60% on Chinese goods and a 25% import surcharge on Canadian and Mexican ...
1don MSN
The International Monetary Fund expects the world economy to grow a little faster and inflation to keep falling this year.
President-elect Trump has expressed support for a negotiated solution with Iran on all outstanding issues, while Iranian ...
Scott Bessent, U.S. President-elect Donald Trump's nominee to be secretary of treasury, looks on as he sits near his son Cole ...
As Donald Trump prepares for his second term, China’s dominance of global manufacturing is greater than ever.
Canada’s draft plan to retaliate against US tariffs may roll out in stages, with the government preparing to hit all American ...
The Canadian dollar weakened against its U.S. counterpart on Friday, with the currency approaching a multi-year low it hit in ...
Tariffs are a wild-card for inflation this year, but it is too soon to say what any changes will mean for the Federal Reserve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback